Welcome to LookChem.com Sign In|Join Free
  • or
Uridine, 3'-deoxy-5-fluorois a modified form of uridine, a nucleoside present in RNA. This chemical compound features a 3'-deoxy and 5-fluoro substitution, classifying it as an analog of uridine. It is recognized for its potential therapeutic effects, especially in the treatment of neurological disorders and cognitive impairments. Uridine, 3'-deoxy-5-fluorohas been studied for its capacity to enhance neuroplasticity, improve memory, and facilitate learning. Additionally, it is under investigation as a possible treatment for diseases like Alzheimer's and Parkinson's.

18829-83-9

Post Buying Request

18829-83-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18829-83-9 Usage

Uses

Used in Pharmaceutical Research and Development:
Uridine, 3'-deoxy-5-fluorois utilized as a research compound for its potential therapeutic effects in the treatment of neurological disorders and cognitive impairments. Its unique structure allows for the exploration of its impact on neuroplasticity, memory, and learning enhancement.
Used in Neurological Disorder Treatment:
In the field of neurology, Uridine, 3'-deoxy-5-fluorois used as a potential treatment for diseases such as Alzheimer's and Parkinson's. Uridine, 3'-deoxy-5-fluoro-'s ability to influence neuroplasticity and cognitive function makes it a promising candidate for further research and development in this area.
Used in Cognitive Enhancement:
Uridine, 3'-deoxy-5-fluorois employed as a cognitive enhancer, aimed at improving memory and learning capabilities. Its effects on neuroplasticity suggest that it could be beneficial for individuals seeking to enhance their cognitive performance.

Check Digit Verification of cas no

The CAS Registry Mumber 18829-83-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,8,2 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 18829-83:
(7*1)+(6*8)+(5*8)+(4*2)+(3*9)+(2*8)+(1*3)=149
149 % 10 = 9
So 18829-83-9 is a valid CAS Registry Number.

18829-83-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Fluoro-3'-deoxyuridine

1.2 Other means of identification

Product number -
Other names 5-Fluor-3'-desoxyuridin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18829-83-9 SDS

18829-83-9Relevant academic research and scientific papers

5′-(2-Nitrophenylalkanoyl)-2′-deoxy-5-fluorouridines as potential prodrugs of FUDR for reductive activation

Liu, Bin,Hu, Longqin

, p. 3889 - 3899 (2007/10/03)

Four 5′-(2-nitrophenylalkanoyl)-2′-deoxy-5-fluorouridines (1a-d) were designed and synthesized as potential prodrugs of FUDR for reductive activation. Two methyl groups were introduced α to the ester carbonyl to increase both the rate of cyclization activation and the stability of the conjugates towards serum esterases. Chemical reduction of the nitro group into an amino leads to cyclization and release of the active FUDR. Kinetic analysis of the cyclization activation process indicates that the two methyl groups α to the ester carbonyl restrict the rotational freedom of ground state molecule and promote the cyclization reaction. However, the two methyl groups also were found to render the conjugates as poor substrates of E. coli B nitroreductase. Conjugate 1c, without the two methyl groups, was reduced by E. coli B nitroreductase (t1/2=8 h) to give two products, a N-hydroxyl lactam and the drug FUDR, suggesting that the enzymatic reduction and subsequent cyclization activation proceeded through the hydroxylamine intermediate. These results indicate that cyclization activation will occur once the nitro group is reduced either to an amino or to a hydroxylamino group. The fact that the amino intermediates cyclized easily to release the incorporated drug FUDR suggests the feasibility of using peptide-linked acyl 2-aminophenylalkanoic acid esters as potential prodrugs for proteolytic activation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 18829-83-9